NantHealth, Inc. / Fundamentals
Income statement
- Net revenue
€55.15M - Cost of goods sold
€21.39M - Gross profit
€33.76M - SG&A expenses
€47.17M - R&D expenses
€16.61M - EBITDA
-€33.11M - D&A
€12.48M - EBIT
-€38.13M - Interest expenses
€15.02M - EBT
-€60.61M - Tax expenses
-€226.51K - Net income
-€60.38M
Cash flow statement
- Net deferred tax
-€267.70K - Non-cash items
€12.91M - Changes in working capital
€9.19M - Operating cash flow
-€23.72M - Capex
€3.76M - Other investing cash flow
€0.00 - Net investing cash flow
-€3.76M - Total cash dividends paid
€0.00 - Issuance of common stock
€6.44M - Debt repayment
€18.82M - Other financing cash flow
€13.89M - Net financing cash flow
€32.71M - Foreign exchange effects
-€742.17K - Net change in cash
€4.50M - Cash at end of period
€6.59M - Free cash flow
-€19.96M
Balance sheet
- Cash and cash equivalents
€5.00M - Cash and short-term investments
€5.00M - Total receivables
€4.25M - Inventory
€0.00 - Other current assets
€3.92M - Total current assets
€13.16M - Property, plant & equipment
€6.47M - Goodwill
€84.37M - Intangible assets
€21.56M - Long-term investments
€0.00 - Other non-current assets
€121.84K - Total non-current assets
€112.52M - Total assets
€125.68M - Accounts payable
€5.72M - Short-term debt
€137.96M - Other current liabilities
€18.44M - Total current liabilities
€163.96M - Long-term debt
€99.39M - Deferred tax liabilities
€1.05M - Other non-current liabilities
€75.49M - Total non-current liabilities
€176.37M - Total liabilities
€340.33M - Common stock
€12.01K - Retained earnings
-€999.90M - Other equity
-€516.52K - Total equity
-€214.65M - Total liabilities and shareholders' equity
€125.68M
Company information
- Market capitalization
€257.75K - Employees
365 - Enterprise Value
€265.65M
Company ratios
- Gross margin
-
61.2% Better than peer group: 42.3% - EBITDA margin
-
-60.0% Much better than peer group: -3,597.5% - EBIT margin
-
-69.1% Much better than peer group: -3,807.5% - EBT margin
-
-109.9% Much better than peer group: -4,062.6% - Net margin
-
-109.5% Much better than peer group: -4,061.0% - ROE
-
28.1% Much worse than peer group: 1,067.3% - ROA
-
-48.0% Much better than peer group: -23,690.7% - Asset turnover
-
43.9% Much worse than peer group: 17,836.9% - FCF margin
-
-49.8% Much better than peer group: -2,960.0% - FCF yield
-10,657.9% - Efficiency ratio
160.0% - Net sales per employee
-
€151.08K - Net income per employee
-
-€165.42K